{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T08:04:28Z","timestamp":1745827468474,"version":"3.37.3"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T00:00:00Z","timestamp":1691712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T00:00:00Z","timestamp":1691712000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100018554","name":"Science and Technology Program of Gansu Province","doi-asserted-by":"publisher","award":["2022B-014"],"award-info":[{"award-number":["2022B-014"]}],"id":[{"id":"10.13039\/501100018554","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Jpn J Radiol"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1007\/s11604-023-01477-0","type":"journal-article","created":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T14:02:18Z","timestamp":1691762538000},"page":"87-95","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Diagnostic potential of [18F]FDG PET\/MRI in non-small cell lung cancer lymph node metastasis: a meta-analysis"],"prefix":"10.1007","volume":"42","author":[{"given":"Min","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenwen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhikang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolei","family":"Yue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiong","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biao","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,8,11]]},"reference":[{"key":"1477_CR1","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1002\/cncr.33587","volume":"127","author":"F Bray","year":"2021","unstructured":"Bray F, Laversanne M, Weiderpass E, et al. The ever-increasing importance of cancer as a leading cause of premature death worldwide. Cancer. 2021;127:3029\u201330.","journal-title":"Cancer"},{"key":"1477_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"1477_CR3","doi-asserted-by":"publisher","first-page":"355","DOI":"10.4065\/83.3.355","volume":"83","author":"T Sher","year":"2008","unstructured":"Sher T, Dy GK, Adjei AA. Small cell lung cancer. Mayo Clin Proc. 2008;83:355\u201367.","journal-title":"Mayo Clin Proc"},{"key":"1477_CR4","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1200\/JCO.2012.46.9270","volume":"31","author":"WD Travis","year":"2013","unstructured":"Travis WD, Brambilla E, Riely GJ. New pathologic classification of lung cancer: relevance for clinical practice and clinical trials. J Clin Oncol. 2013;31:992\u20131001.","journal-title":"J Clin Oncol"},{"key":"1477_CR5","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1056\/NEJM200007273430404","volume":"343","author":"RM Pieterman","year":"2000","unstructured":"Pieterman RM, van Putten JW, Meuzelaar JJ, et al. Preoperative staging of non-small-cell lung cancer with positron-emission tomography. N Engl J Med. 2000;343:254\u201361.","journal-title":"N Engl J Med"},{"key":"1477_CR6","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1093\/ejcts\/ezu028","volume":"45","author":"P De Leyn","year":"2014","unstructured":"De Leyn P, Dooms C, Kuzdzal J, et al. Revised ESTS guidelines for preoperative mediastinal lymph node staging for non-small-cell lung cancer. Eur J Cardiothorac Surg. 2014;45:787\u201398.","journal-title":"Eur J Cardiothorac Surg"},{"key":"1477_CR7","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/S0003-4975(98)00675-4","volume":"66","author":"W Weder","year":"1998","unstructured":"Weder W, Schmid RA, Bruchhaus H, et al. Detection of extrathoracic metastases by positron emission tomography in lung cancer. Ann Thorac Surg. 1998;66:886\u201392.","journal-title":"Ann Thorac Surg"},{"key":"1477_CR8","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1016\/0003-4975(95)00752-0","volume":"60","author":"PE Valk","year":"1995","unstructured":"Valk PE, Pounds TR, Hopkins DM, et al. Staging non-small cell lung cancer by whole-body positron emission tomographic imaging. Ann Thorac Surg. 1995;60:1573\u201381.","journal-title":"Ann Thorac Surg"},{"key":"1477_CR9","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1136\/thx.50.12.1267","volume":"50","author":"T Arita","year":"1995","unstructured":"Arita T, Kuramitsu T, Kawamura M, et al. Bronchogenic carcinoma: incidence of metastases to normal sized lymph nodes. Thorax. 1995;50:1267\u20139.","journal-title":"Thorax"},{"key":"1477_CR10","doi-asserted-by":"publisher","DOI":"10.1102\/1470-7330.2008.9006","author":"S Rankin","year":"2008","unstructured":"Rankin S. PET\/CT for staging and monitoring non small cell lung cancer. Cancer Imaging. 2008. https:\/\/doi.org\/10.1102\/1470-7330.2008.9006.","journal-title":"Cancer Imaging"},{"key":"1477_CR11","doi-asserted-by":"publisher","first-page":"3471","DOI":"10.1021\/acs.molpharmaceut.2c00353","volume":"19","author":"Q Wang","year":"2022","unstructured":"Wang Q, Zhang X, Wei W, et al. PET imaging of lung cancers in precision medicine: current landscape and future perspective. Mol Pharm. 2022;19:3471\u201383.","journal-title":"Mol Pharm"},{"key":"1477_CR12","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1053\/j.semnuclmed.2022.04.004","volume":"52","author":"R Manafi-Farid","year":"2022","unstructured":"Manafi-Farid R, Askari E, Shiri I, et al. [(18)F]FDG-PET\/CT radiomics and artificial intelligence in lung cancer: technical aspects and potential clinical applications. Semin Nucl Med. 2022;52:759\u201380.","journal-title":"Semin Nucl Med"},{"issue":"8","key":"1477_CR13","doi-asserted-by":"publisher","first-page":"561","DOI":"10.3390\/diagnostics10080561","volume":"10","author":"K Kaseda","year":"2020","unstructured":"Kaseda K. Recent and current advances in FDG-pet imaging within the field of clinical oncology in NSCLC: a review of the literature. Diagnostics (Basel). 2020;10(8):561.","journal-title":"Diagnostics (Basel)"},{"key":"1477_CR14","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.jss.2012.03.074","volume":"178","author":"LM Wu","year":"2012","unstructured":"Wu LM, Xu JR, Gu HY, et al. Preoperative mediastinal and hilar nodal staging with diffusion-weighted magnetic resonance imaging and fluorodeoxyglucose positron emission tomography\/computed tomography in patients with non-small-cell lung cancer: which is better? J Surg Res. 2012;178:304\u201314.","journal-title":"J Surg Res"},{"key":"1477_CR15","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1148\/radiol.2432060131","volume":"243","author":"M Matoba","year":"2007","unstructured":"Matoba M, Tonami H, Kondou T, et al. Lung carcinoma: diffusion-weighted mr imaging\u2013preliminary evaluation with apparent diffusion coefficient. Radiology. 2007;243:570\u20137.","journal-title":"Radiology"},{"key":"1477_CR16","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12880-021-00580-w","volume":"21","author":"A Al-Ibraheem","year":"2021","unstructured":"Al-Ibraheem A, Hirmas N, Fanti S, et al. Impact of (18)F-FDG PET\/CT, CT and EBUS\/TBNA on preoperative mediastinal nodal staging of NSCLC. BMC Med Imaging. 2021;21:49.","journal-title":"BMC Med Imaging"},{"key":"1477_CR17","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1007\/s12149-022-01795-9","volume":"36","author":"A Kajiyama","year":"2022","unstructured":"Kajiyama A, Ito K, Watanabe H, et al. Consistency and prognostic value of preoperative staging and postoperative pathological staging using (18)F-FDG PET\/MRI in patients with non-small cell lung cancer. Ann Nucl Med. 2022;36:1059\u201372.","journal-title":"Ann Nucl Med"},{"key":"1477_CR18","first-page":"196","volume":"25","author":"J Sun","year":"2022","unstructured":"Sun J, Li Y, Gong F, et al. The diagnostic value of PET\/CT for the lymph node metastasis in Asian patients with non-small cell lung cancer: A meta-analysis. Hell J Nucl Med. 2022;25:196\u2013204.","journal-title":"Hell J Nucl Med"},{"key":"1477_CR19","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.suronc.2011.11.001","volume":"21","author":"L Zhao","year":"2012","unstructured":"Zhao L, He ZY, Zhong XN, et al. (18)FDG-PET\/CT for detection of mediastinal nodal metastasis in non-small cell lung cancer: a meta-analysis. Surg Oncol. 2012;21:230\u20136.","journal-title":"Surg Oncol"},{"key":"1477_CR20","first-page":"Cd009519","volume":"2014","author":"M Schmidt-Hansen","year":"2014","unstructured":"Schmidt-Hansen M, Baldwin DR, Hasler E, et al. PET-CT for assessing mediastinal lymph node involvement in patients with suspected resectable non-small cell lung cancer. Cochrane Database Syst Rev. 2014;2014:Cd009519.","journal-title":"Cochrane Database Syst Rev"},{"key":"1477_CR21","doi-asserted-by":"publisher","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","volume":"155","author":"PF Whiting","year":"2011","unstructured":"Whiting PF, Rutjes AW, Westwood ME, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155:529\u201336.","journal-title":"Ann Intern Med"},{"key":"1477_CR22","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0140-6736(05)62352-5","volume":"350","author":"JA Berlin","year":"1997","unstructured":"Berlin JA. Does blinding of readers affect the results of meta-analyses? University of Pennsylvania Meta-analysis Blinding Study Group. Lancet. 1997;350:185\u20136.","journal-title":"Lancet"},{"key":"1477_CR23","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1471-2288-6-31","volume":"6","author":"J Zamora","year":"2006","unstructured":"Zamora J, Abraira V, Muriel A, et al. Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol. 2006;6:31.","journal-title":"BMC Med Res Methodol"},{"key":"1477_CR24","doi-asserted-by":"publisher","first-page":"373","DOI":"10.2967\/jnumed.113.129825","volume":"55","author":"P Heusch","year":"2014","unstructured":"Heusch P, Buchbender C, K\u00f6hler J, et al. Thoracic staging in lung cancer: prospective comparison of 18F-FDG PET\/MR imaging and 18F-FDG PET\/CT. J Nucl Med. 2014;55:373\u20138.","journal-title":"J Nucl Med"},{"key":"1477_CR25","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00259-014-2873-9","volume":"42","author":"F Fraioli","year":"2015","unstructured":"Fraioli F, Screaton NJ, Janes SM, et al. Non-small-cell lung cancer resectability: diagnostic value of PET\/MR. Eur J Nucl Med Mol Imaging. 2015;42:49\u201355.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1477_CR26","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1148\/radiol.14140936","volume":"275","author":"Y Ohno","year":"2015","unstructured":"Ohno Y, Koyama H, Yoshikawa T, et al. Three-way comparison of whole-body MR, coregistered whole-body FDG PET\/MR, and integrated whole-body FDG PET\/CT imaging: TNM and stage assessment capability for non-small cell lung cancer patients. Radiology. 2015;275:849\u201361.","journal-title":"Radiology"},{"key":"1477_CR27","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2967\/jnumed.115.162040","volume":"57","author":"MW Huellner","year":"2016","unstructured":"Huellner MW, Galiza Barbosa FD, Husmann L, et al. TNM staging of non-small cell lung cancer: comparison of PET\/MR and PET\/CT. J Nucl Med. 2016;57:21\u20136.","journal-title":"J Nucl Med"},{"key":"1477_CR28","doi-asserted-by":"publisher","first-page":"3850","DOI":"10.1007\/s00330-016-4255-0","volume":"26","author":"SM Lee","year":"2016","unstructured":"Lee SM, Goo JM, Park CM, et al. Preoperative staging of non-small cell lung cancer: prospective comparison of PET\/MR and PET\/CT. Eur Radiol. 2016;26:3850\u20137.","journal-title":"Eur Radiol"},{"key":"1477_CR29","doi-asserted-by":"crossref","first-page":"S502","DOI":"10.1007\/s00259-018-4102-4","volume":"45","author":"J Kirchner","year":"2018","unstructured":"Kirchner J, Sawicki LM, Schaarschmidt BM, et al. Prospective comparison of 18F-FDG PET\/MRI and 18F-FDG PET\/CT for thoracic staging of non-small cell lung cancer. Eur J Nucl Med Mol Imaging. 2018;45:S502.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1477_CR30","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.2214\/AJR.19.22565","volume":"215","author":"Y Ohno","year":"2020","unstructured":"Ohno Y, Takeshi Y, Takenaka D, et al. Comparison of diagnostic accuracy for TNM stage among whole-body MRI and coregistered PET\/MRI using 1.5-T and 3-T MRI systems and integrated PET\/CT for non-small cell lung cancer. Am J Roentgenol. 2020;215:1191\u20138.","journal-title":"Am J Roentgenol"},{"issue":"12","key":"1477_CR31","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1007\/s12149-022-01795-9","volume":"36","author":"A Kajiyama","year":"2022","unstructured":"Kajiyama A, Ito K, Watanabe H, et al. Consistency and prognostic value of preoperative staging and postoperative pathological staging using(18)F-FDG PET\/MRI in patients with non-small cell lung cancer. Ann Nucl Med. 2022;36(12):1059\u201372.","journal-title":"Ann Nucl Med"},{"key":"1477_CR32","first-page":"16","volume":"42","author":"M-L Wang","year":"2022","unstructured":"Wang M-L, Zhang H, Yu H-J, et al. An initial study on the comparison of diagnostic performance of 18F-FDG PET\/MR and 18F-FDG PET\/CT for thoracic staging of non-small cell lung cancer: Focus on pleural invasion. Rev Esp Med Nucl Imagen Mol. 2022;42:16\u201323.","journal-title":"Rev Esp Med Nucl Imagen Mol"},{"key":"1477_CR33","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.mcna.2018.12.006","volume":"103","author":"F Nasim","year":"2019","unstructured":"Nasim F, Sabath BF, Eapen GA. Lung cancer. Med Clin North Am. 2019;103:463\u201373.","journal-title":"Med Clin North Am"},{"key":"1477_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0022-5223(19)37318-0","volume":"83","author":"FG Pearson","year":"1982","unstructured":"Pearson FG, DeLarue NC, Ilves R, et al. Significance of positive superior mediastinal nodes identified at mediastinoscopy in patients with resectable cancer of the lung. J Thorac Cardiovasc Surg. 1982;83:1\u201311.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1477_CR35","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S0022-5223(94)70486-4","volume":"107","author":"P Goldstraw","year":"1994","unstructured":"Goldstraw P. The role of mediastinoscopic biopsy in preoperative assessment of lung cancer. J Thorac Cardiovasc Surg. 1994;107:309\u201311.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1477_CR36","doi-asserted-by":"publisher","first-page":"e211S","DOI":"10.1378\/chest.12-2355","volume":"143","author":"GA Silvestri","year":"2013","unstructured":"Silvestri GA, Gonzalez AV, Jantz MA, et al. Methods for staging non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143:e211S \u2013 e250.","journal-title":"Chest"},{"key":"1477_CR37","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1148\/rg.232025705","volume":"23","author":"L Kostakoglu","year":"2003","unstructured":"Kostakoglu L, Agress H Jr, Goldsmith SJ. Clinical role of FDG PET in evaluation of cancer patients. Radiographics. 2003;23:315\u201340. https:\/\/doi.org\/10.1148\/rg.232025705.","journal-title":"Radiographics"},{"key":"1477_CR38","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1007\/s00330-008-0857-5","volume":"18","author":"BJ Pichler","year":"2008","unstructured":"Pichler BJ, Judenhofer MS, Wehrl HF. PET\/MRI hybrid imaging: devices and initial results. Eur Radiol. 2008;18:1077\u201386.","journal-title":"Eur Radiol"},{"key":"1477_CR39","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/nm1700","volume":"14","author":"MS Judenhofer","year":"2008","unstructured":"Judenhofer MS, Wehrl HF, Newport DF, et al. Simultaneous PET-MRI: a new approach for functional and morphological imaging. Nat Med. 2008;14:459\u201365.","journal-title":"Nat Med"},{"key":"1477_CR40","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1007\/s00259-020-04955-z","volume":"48","author":"SE Dahlsgaard-Wallenius","year":"2021","unstructured":"Dahlsgaard-Wallenius SE, Hildebrandt MG, Johansen A, et al. Hybrid PET\/MRI in non-small cell lung cancer (NSCLC) and lung nodules-a literature review. Eur J Nucl Med Mol Imaging. 2021;48:584\u201391.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1477_CR41","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1007\/978-3-030-42618-7_22","volume":"216","author":"W Weber","year":"2020","unstructured":"Weber W. Clinical PET\/MR. Rec Results Cancer Res. 2020;216:747\u201364.","journal-title":"Rec Results Cancer Res"},{"key":"1477_CR42","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1002\/sim.942","volume":"20","author":"CM Rutter","year":"2001","unstructured":"Rutter CM, Gatsonis CA. A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations. Stat Med. 2001;20:2865\u201384.","journal-title":"Stat Med"},{"key":"1477_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0173104","volume":"12","author":"G Shen","year":"2017","unstructured":"Shen G, Lan Y, Zhang K, et al. Comparison of 18F-FDG PET\/CT and DWI for detection of mediastinal nodal metastasis in non-small cell lung cancer: A meta-analysis. PLoS ONE. 2017;12: e0173104.","journal-title":"PLoS ONE"},{"issue":"Suppl 1","key":"1477_CR44","doi-asserted-by":"publisher","first-page":"122s","DOI":"10.2967\/jnumed.108.057307","volume":"50","author":"RL Wahl","year":"2009","unstructured":"Wahl RL, Jacene H, Kasamon Y, et al. From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors. J Nucl Med. 2009;50(Suppl 1):122s-s150.","journal-title":"J Nucl Med"},{"key":"1477_CR45","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s40644-015-0053-1","volume":"15","author":"K Miles","year":"2015","unstructured":"Miles K, McQueen L, Ngai S, et al. Evidence-based medicine and clinical fluorodeoxyglucose PET\/MRI in oncology. Cancer Imaging. 2015;15:18.","journal-title":"Cancer Imaging"},{"key":"1477_CR46","doi-asserted-by":"publisher","first-page":"845","DOI":"10.2967\/jnumed.111.098608","volume":"53","author":"A Drzezga","year":"2012","unstructured":"Drzezga A, Souvatzoglou M, Eiber M, et al. First clinical experience with integrated whole-body PET\/MR: comparison to PET\/CT in patients with oncologic diagnoses. J Nucl Med. 2012;53:845\u201355.","journal-title":"J Nucl Med"}],"container-title":["Japanese Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11604-023-01477-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11604-023-01477-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11604-023-01477-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T18:11:55Z","timestamp":1704305515000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11604-023-01477-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,11]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["1477"],"URL":"https:\/\/doi.org\/10.1007\/s11604-023-01477-0","relation":{},"ISSN":["1867-1071","1867-108X"],"issn-type":[{"type":"print","value":"1867-1071"},{"type":"electronic","value":"1867-108X"}],"subject":[],"published":{"date-parts":[[2023,8,11]]},"assertion":[{"value":"2 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}